Lv41
410 积分 2022-08-02 加入
STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
19分钟前
待确认
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
47分钟前
已完结
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
50分钟前
已完结
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study
6个月前
已完结
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
6个月前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
8个月前
已完结
An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low)
11个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
1年前
已完结
460MO Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers
1年前
已关闭
ARX788, a Site-specific Anti-HER2 Antibody-Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1-resistant Breast and Gastric Cancers
1年前
已完结
皖公网安备34019202002308
